statistiche ricercatore

statistiche per INGEGNOLI, FRANCESCA ANNA

Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5385
NA - Nord America 2889
AS - Asia 1904
SA - Sud America 196
OC - Oceania 35
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 8
Totale 10432
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2802
GB - Regno Unito 2666
CN - Cina 1237
IT - Italia 1033
DE - Germania 385
FR - Francia 323
TR - Turchia 192
KR - Corea 168
FI - Finlandia 117
DK - Danimarca 115
UA - Ucraina 114
RU - Federazione Russa 109
IN - India 107
EU - Europa 106
NL - Olanda 104
ES - Italia 91
JP - Giappone 83
CO - Colombia 75
SE - Svezia 71
GR - Grecia 68
BR - Brasile 55
CA - Canada 55
PL - Polonia 41
HK - Hong Kong 36
AU - Australia 34
AR - Argentina 32
BE - Belgio 26
MX - Messico 23
CH - Svizzera 17
PT - Portogallo 16
RO - Romania 15
CL - Cile 14
CZ - Repubblica Ceca 14
AT - Austria 13
PE - Perù 12
HU - Ungheria 11
TW - Taiwan 11
ID - Indonesia 10
IL - Israele 10
NO - Norvegia 7
TH - Thailandia 7
VN - Vietnam 7
IR - Iran 6
RS - Serbia 6
HR - Croazia 5
MY - Malesia 5
PH - Filippine 5
TN - Tunisia 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
EG - Egitto 4
SG - Singapore 4
SI - Slovenia 4
LU - Lussemburgo 3
PR - Porto Rico 3
QA - Qatar 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
CR - Costa Rica 2
CU - Cuba 2
LB - Libano 2
LV - Lettonia 2
MA - Marocco 2
SK - Slovacchia (Repubblica Slovacca) 2
BA - Bosnia-Erzegovina 1
BT - Bhutan 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GP - Guadalupe 1
IE - Irlanda 1
KE - Kenya 1
LK - Sri Lanka 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SD - Sudan 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 10532
Salva come PNG Salva come JPEG
Città #
Southend 2422
Milan 437
Seattle 343
Beijing 257
Wilmington 241
Dearborn 224
Fairfield 209
Ann Arbor 176
Nanjing 171
Houston 146
Jacksonville 139
Redwood City 134
Woodbridge 133
Redmond 106
Mountain View 90
Ashburn 85
Jinan 75
Shenyang 75
Cambridge 73
Serra 72
Changsha 70
Bogotá 57
Athens 53
Hebei 53
Sakarya 53
Somerville 50
Guangzhou 43
Nanchang 40
Fremont 38
Tianjin 38
Sunnyvale 36
Hangzhou 35
Kunming 28
Shanghai 26
Jiaxing 23
Los Angeles 23
Seoul 23
Zhengzhou 21
Ningbo 20
Phoenix 20
Tokyo 20
Bitonto 18
Central District 18
Margão 18
Hefei 17
Ottawa 17
Rome 17
Warsaw 17
Chengdu 16
Haikou 16
Santa Rosa 16
Taiyuan 16
Duncan 15
Lanzhou 15
Kiez 14
Berlin 13
Munro 13
Scranton 13
Leiden 12
A Shan 11
Barcelona 11
Fuzhou 11
Taizhou 11
Verona 11
Hamburg 10
Madrid 10
Santiago 10
São Paulo 10
Buenos Aires 9
Saint Petersburg 9
Lima 8
New York 8
Silver Spring 8
Auburn Hills 7
Hanoi 7
Providence 7
Ankara 6
Detroit 6
Fort Worth 6
Jakarta 6
London 6
Vienna 6
Xian 6
Zurich 6
Bangalore 5
Brooklyn 5
Dallas 5
Edinburgh 5
Erlangen 5
Gent 5
Leeds 5
Medellín 5
Nijmegen 5
Nürnberg 5
Polska 5
Taipei 5
Toronto 5
Vigo 5
Atlanta 4
Belgrade 4
Totale 6943
Salva come PNG Salva come JPEG
Nome #
Update of EULAR recommendations for the treatment of systemic sclerosis 1160
Anticorpi anti-peptide citrullinato ciclico in pazienti con artropatia sclerodermica 273
Reliability of simple capillaroscopic definitions in describing capillary morphology in rheumatic diseases 206
Ruolo della videocapillaroscopia periungueale in pazienti con dermato/polimiosite idiopatica dell’adulto e infantile 203
Evaluation of nailfold videocapillaroscopic abnormalities in patients with systemic lupus erythematosus 191
Activation of inflammation, coagulation and fibrinolysis in patients with Rheumatoid Arthritis : inhibition by Tumor Necrosis Factor alpha blockade 180
Smac127 Has Proapoptotic and Anti-Inflammatory Effects on Rheumatoid Arthritis Fibroblast-Like Synoviocytes 152
Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis 143
Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis : effects of tumor necrosis factor-alpha blockade 133
Un nuovo algoritmo prognostico basato su parametri capillaroscopici e autoanticorpali per identificare i soggetti con fenomeno di Raynaud a rischio di sviluppare sclerosi sistemica 126
Current perspective on rituximab in rheumatic diseases 116
L’impegno articolare della Sclerosi Sistemica 111
Valutazione del dannno anatomico e funzionale della mano nei pazienti con sclerosi sistemica 107
Haemostatic and inflammatory biomarkers in patients with rheumatoid arthritis : effect of tumor necrosis factor alpha blockade 107
Outcomes, rates and predictors of transition of isolated Raynaud's phenomenon : a systematic review and meta-analysis 106
La terapia della dermato-polimiosite 99
Feasibility, acceptability and construct validity of EQ-5D in systemic sclerosis 98
Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis. 98
Phenotypes determined by cluster analysis and their survival in the prospective EUSTAR cohort of patients with systemic sclerosis 98
Health-related quality of life burden in scleroderma patients treated with two different intravenous iloprost regimens 93
IL-10-producing forkhead box protein 3-negative regulatory T cells inhibit B-cell responses and are involved in systemic lupus erythematosus 92
Bronchus-associated lymphoid tissue lymphoma in a patient with primary Sjögren's syndrome 90
Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder : PRINCE (prognostic index for nailfold capillaroscopic examination) 89
Evaluation of nailfold videocapillaroscopic abnormalities in patients with systemic lupus erythematosus 89
Comparative analysis of different indices of hand disability in systemic sclerosis 88
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis : A EUSTAR analysis 86
IL-10 producing CCR6+T-cells are a distinct population of B-helper T-cells that play a pathogenic role in systemic lupus erythematosus 86
Nailfold capillaroscopic report : qualitative and quantitative methods 85
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus 85
A multi-national qualitative research study exploring the patient experience of Raynaud's phenomenon in systemic sclerosis 85
Bilateral vocal fold immobility in a patient with overlap syndrome rheumatoid arthritis/systemic sclerosis 85
Utility and reliability of different capillaroscopic measures for the identification of secondary Raynaud’s phenomenon 85
Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon : role of autoantibodies and nail-fold capillaroscopy 84
Effectiveness and safety of oxycodone/naloxone in the management of chronic pain in patients with systemic sclerosis with recurrent digital ulcers : Two case reports 83
Effect of tumor necrosis factor alpha blockade on inflammatory and haemostatic biomarkers in patients with rheumatoid arthritis 83
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis 83
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis 82
Systemic sclerosis, capillary leak syndrome and nasopharyngeal carcinoma : an unusual association or paraneoplastic manifestations? 81
Practical Management of Cardiovascular Comorbidities in Rheumatoid Arthritis 81
Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts 81
Hyperferritinemia is Associated with Serologic Antiphospholipid Syndrome in SLE Patientsin 80
Le ulcere cutanee nella Sclerosi Sistemica 79
Capillaroscopic observations in childhood rheumatic diseases and healthy controls 79
Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosis 76
Reduction of haemostatic and inflammatory biomarkers by tumor necrosis factor-alpha bockade in patients with rheumatoid arthritis 76
Feasibility of different capillaroscopic measures for identifying nailfold microvascular alterations 75
Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis 74
Effetto della terapia con infliximab sui marcatori di infiammazione, coagulazione e fibrinolisi nell’artrite reumatoide 73
Haemostatic and inflammatory biomarkers in patients with active Rheumatoid Arthritis : effects of Tumor Necrosis Factor alpha blockade 73
Diagnostic validity in detecting different capillaroscopic patterns by qualitative versus quantitative scoring methods 73
A novel prognostic rule-based scheme for identifying Raynaud’s phenomenon patients at high risk for the development of systemic sclerosis using capillaroscopy and autoantibodies 71
Evidence of macro- and micro-angiopathy in scleroderma: An integrated approach combining 22-MHz power Doppler ultrasonography and video-capillaroscopy 71
Reliability and validity of the Italian version of the hand functional disability scale in patients with systemic sclerosis 71
Scleroderma-like pattern in patients with systemic lupus erythematosus (SLE): a red flag for overlap syndrome SLE/systemic sclerosis? 71
PRINCE: prognostic index for nailfold capillaroscopic examination for identifying raynaud's phenomenon at high risk of developing into a scleroderma spectrum disorder 69
Primary antiphospolipid syndrome associated with small aorta syndrome: a case report. 68
Hand impairment in systemic sclerosis : association of different hand indices with organ involvement 67
Distinct immune profiles characterize patients with diffuse or limited systemic sclerosis 67
Assessment of musculoskeletal hand involvement in systemic sclerosis using ultrasonography and plain radiography 66
COVID-19 infection and rheumatoid arthritis: Faraway, so close! 66
Assessment of negative prognostic factors in patients affected by systemic sclerosis with cardiac involvement. A retrospective study 65
The efficacy and cost effectiveness of iloprost in the treatment of systemic sclerosis: a comparative analysis 65
Valutazione dei fattori prognostici negativi in pazienti affetti da sclerosi sistemica con coinvolgimento cardiaco: studio retrospettivo 65
A systematic review of systemic sclerosis instruments for the eular outcome measures library : An evolutionary database of validated patient-reported instruments 64
Digital ulcer management in patients with systemic sclerosis 63
Hand impairement in systemic sclerosis : a comparative analysis of different functional indices in a cross-sectional study 62
La valutazione della qualità della vita nei pazienti con sclerodermia=Health related quality of life assessment in patients with systemic sclerosis 62
A cross-sectional, international survey on non-invasive techniques to assess the microcirculation in patients with Raynaud's phenomenon (Sunshine Survey) 62
Tocilizumab monotherapy in a patient with rheumatoid arthritis and iatrogenic kaposi sarcoma 61
Uniphasic blanching of the fingers, abnormal capillaroscopy in nonsymptomatic digits, and autoantibodies: expanding options to increase the level of suspicion of connective tissue diseases beyond the classification of Raynaud's Phenomenon 61
An Eular Study Group Pilot Study on Reliability of “Simple” Capillaroscopic Definitions to Describe Capillary Morphology in Rheumatic Diseases : AB1086  60
Proapoptotic Activity of a Monomeric Smac Mimetic on Human Fibroblast-Like Synoviocytes from Patients with Rheumatoid Arthritis 59
The Adipose Mesenchymal Stem Cell Secretome Inhibits Inflammatory Responses of Microglia : Evidence for an Involvement of Sphingosine-1-Phosphate Signalling 59
Prolactin and autoimmunity : hyperprolactinemia correlates with serositis and anemia in SLE patients 58
Mesenchymal stem cells : potential for therapy and treatment of chronic non-healing skin wounds 58
Disease subsets, autoantibodies and clinical features in 176 adult italian patients with systemic sclerosis : A cross sectional study 58
The role of ultrasonography in the assessment of skeletal hand involvement in systemic sclerosis 57
Outcomes, rates, and risk factors of transition of Raynaud's phenomenon to a connective tissue disease: systematic review and meta-analysis 57
Comparative analysis of different specific indices of hand impairment in systemic sclerosis 54
Does polymorphysm of genes coding for pro-inflammatory mediators predict the clinical response to tnf alpha blocking agents? A review analysis of the literature 53
Differential impairment of serum cholesterol efflux capacity in patients with rheumatoid arthritis and systemic lupus erythematosus 50
Potential effect of anti-tumour necrosis factor-alpha treatment on reducing the cardiovascular risk related to rheumatoid arthritis 48
Choroidal impairment and macular thinning in patients with systemic sclerosis : the acute study 48
Prothrombotic biomarkers in patients with rheumatoid arthritis : the beneficial effect of IL-6 receptor blockade 48
Vascular changes in chorid plexus in patients with Raynaud's phenomenon suspected secondary to a connective tissue disease 48
Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients : a single centre study and review of the literature 47
Sequential anti-osteoporotic therapy against recurrence of fragility fractures : the positive clinical effects of an osteo-anabolic first choice 47
Nailfold capillary patterns in healthy subjects : a real issue in capillaroscopy 45
Lysyl oxidase-a possible role in systemic sclerosis-associated pulmonary hypertension : a multicentre study 45
Power doppler sonography and clinical monitoring of short and long term efficacy of high molecular weight hyaluronic acid injection in the osteoarthritis of the thumb base 44
Update on the epidemiology, risk factors, and disease outcomes of systemic sclerosis 44
Power Doppler sonography and clinical monitoring for hyaluronic Acid treatment of rhizarthrosis : a pilot study 43
The prognostic role of nailfold capillaroscopy in the differential diagnosis of Raynaud’s phenomenon 42
Role of anti-IFI16 antibodies and NT-proBNP as candidate biomarkers in systemic sclerosis 42
Watermelon stomach in systemic sclerosis : a Eustar case-control study 42
A systematic overview on the use and relevance of capillaroscopy in systemic sclerosis 41
Watermelon stomach in systemic sclerosis : A EUSTAR case-control study 41
Sparing effect of hemiplegia on skin fibrosis and microvascular involvement: Reports of two cases of systemic sclerosis and review of the literature 41
N-TproBNP as biomarker in systemic sclerosis 40
Systemic sclerosis and myositis extractable nuclear antigen (ENA) analysis : profile of a cohort of subjects with isolated Raynaud's phenomenon 40
Totale 9037
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11662
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11662
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2015/201624 0000 00 100 6431
2016/2017891 1983220 2828 5511 202036047
2017/20181467 176151126199 85207 7447 956714595
2018/20192069 450150104209 37157 29972 18392212104
2019/20203354 3897985197 184425 414231 546457185162
2020/20211939 281251262191 338384 2320 0000
Totale 11662
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie
Logo CINECA  Copyright © 2021